Illumina shareholders have voted to oust the company’s chairman John Thompson, although chief executive Francis DeSouza has emerged from the annual meeting unscathed.
The Federal Trade Commission has ordered Illumina to divest Grail, the cancer detection business it bought for $7.1 billion in 2021, saying it will “stifle” competition an
Illumina has bitten back against the attempt by billionaire activist investor Carl Icahn to introduce three members to its board, saying that they lack “experience in and
Billionaire activist investor and ‘corporate raider’ Carl Icahn is lining up a proxy battle at Illumina in the wake of its troubled $7.1 billion takeover of blood-based ca